跳至主要内容
临床试验/NCT02533440
NCT02533440已完成不适用

A Prospective, Randomized, Open-Label Study Comparing Postsurgical Analgesia Using EXPAREL® To Standard Of Care For The Full Arch Surgical Therapy (FAST) Dental Implant Surgery Procedure

Bellaire Facial Surgery Center4 个研究点 分布在 1 个国家目标入组 69 人开始时间: 2015年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
69
试验地点
4
主要终点
Postsurgical Pain Severity

研究概览

简要总结

This study is researching managing postsurgical pain by injecting both short-acting local anesthetics and EXPAREL® at the time of surgery and reviewing if it could reduce or eliminate the need for postsurgical opioids and improve clinical outcomes following the FAST dental implant surgery procedure. This approach is being compared to the current standard of care.

详细描述

Postsurgical pain following the Full Arch Surgical Therapy (FAST) dental implant surgery procedure is commonly managed with a variety of interventions, including local infiltration with short-acting local anesthetics during surgery and the use of postsurgical opioid and non-opioid analgesics. Although this approach to managing postsurgical pain is considered the current standard of care, its reliance on opioid analgesics to provide analgesia beyond the duration of short-acting local anesthetics exposes patients to opioid-related adverse events (ORAEs) that may delay their recovery and have other deleterious clinical consequences. The primary objective of this study is to determine the efficacy and safety of local infiltration of EXPAREL for the FAST dental implant surgery procedure compared to standard of care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older;
  • Ability to speak, read, and write in English;
  • Ability to communicate via telephone;
  • Scheduled to undergo FAST dental implant surgery procedure at a study center within the next 30 days for both maxillary and mandibular repair with at least 4 upper and 4 lower teeth to be extracted;
  • Willing to provide informed consent, participate in study, and comply with study protocol.

排除标准

  • Daily opioid consumption for more than 30 days prior to surgery;
  • Any opioid consumption within 3 days prior to surgery.
  • Prior treatment for alcohol, recreational drug, or opioid abuse.
  • Hypersensitivity or allergy to local anesthetics, non steroidal anti-inflammatory drugs, or opioids;
  • Breastfeeding, pregnant, or contemplating pregnancy prior to surgery.

结局指标

主要结局

Postsurgical Pain Severity

时间窗: 7 days

次要结局

  • Analgesic medication use(7 days)
  • Incidence of ORAEs and other adverse events (AEs)(7 days)
  • Food ingesting tolerance(7 days)
  • Patient Satisfaction(7 days)

研究者

发起方
Bellaire Facial Surgery Center
申办方类型
Other
责任方
Principal Investigator
主要研究者

Phillip T. Iero

Oral Surgeon

Bellaire Facial Surgery Center

研究点 (4)

Loading locations...

相似试验